MainboardNSELISTED

Sahajanand Medical IPO

₹327 – ₹327 · Issue Size ₹475.5 Cr

IPO Overview

StatusListed
Price Band₹327 – ₹327
Issue Size₹475.5 Cr
Lot Size43 shares
Min Investment₹14,792
Face Value₹1
Issue Structure
Fresh Issue—
Offer for Sale₹1,38,22,116 Cr
Total Size₹475.5 Cr

IPO Timeline

Open Date15 Oct 2026
Close Date19 Oct 2026
Allotment21 Oct 2026
Refund22 Oct 2026
Credit to Demat22 Oct 2026
Listing Date23 Oct 2026

Listing Performance

Issue Price₹327 – ₹327
Listing Price—
Listing Gain—

Management & Promoters

Bhargav Dhirajlal KotadiaDhirajlal Vallabhbhai KotadiaPriyanka Dhirajlal Cohen and Shree Hari Trust

Shareholding Pattern

Promoters
Bhargav Dhirajlal KotadiaDhirajlal Vallabhbhai KotadiaPriyanka Dhirajlal Cohen and Shree Hari Trust

About

Incorporated in 2001, Sahajanand Medical Technologies is a medical device firm that focuses on Class III and Class C/D devices, mainly working in the fields of vascular and structural heart intervention. The company was the first globally to achieve CE certification for a drug-eluting stent (DES) with a biodegradable polymer, Infinnium. Its product range is divided into 3 main categories: Vascular Intervention (VI), Structural Heart (SH), and other products. Sahajanand operates two R&D centers,

ExchangeNSE
Issue Typemainboard
Face Value₹1 per share

rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.